These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23157790)

  • 1. Drug-induced dermatomyositis after zoledronic acid.
    Tong PL; Yu LL; Chan JJ
    Australas J Dermatol; 2012 Nov; 53(4):e73-5. PubMed ID: 23157790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible zoledronic acid-induced dermatomyositis.
    Apalla Z; Tzellos T; Lallas A; Sotiriou E; Lefaki I
    Clin Exp Dermatol; 2012 Apr; 37(3):309-11. PubMed ID: 22007911
    [No Abstract]   [Full Text] [Related]  

  • 3. Zoledronic Acid-Induced Interface Dermatitis.
    Succaria F; Collier M; Mahalingam M
    Am J Dermatopathol; 2015 Dec; 37(12):933-5. PubMed ID: 26588338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant cell arteritis with visual loss following zoledronic acid infusion.
    Metyas S; Ibrahim M; Solyman J; Yeter KC; Arkfeld DG
    Int J Rheum Dis; 2014 Jan; 17(1):113-5. PubMed ID: 24472274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizures associated with zoledronic acid for osteoporosis.
    Tsourdi E; Rachner TD; Gruber M; Hamann C; Ziemssen T; Hofbauer LC
    J Clin Endocrinol Metab; 2011 Jul; 96(7):1955-9. PubMed ID: 21508139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid.
    Cohen PR
    Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: report of 2 cases.
    Lee JJ; Cheng SJ; Wang YP; Jeng JH; Chiang CP; Kok SH
    Head Neck; 2013 Jan; 35(1):E6-10. PubMed ID: 21523843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB
    Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute anterior uveitis associated with the use zoledronic acid].
    Cavallasca JA; Reyt C
    Medicina (B Aires); 2014; 74(5):428-9. PubMed ID: 25347912
    [No Abstract]   [Full Text] [Related]  

  • 10. Unilateral anterior uveitis complicating zoledronic acid therapy in prostate cancer.
    Banal F; Briot K; Ayoub G; Dougados M; Roux C
    J Rheumatol; 2008 Dec; 35(12):2458-9. PubMed ID: 19040323
    [No Abstract]   [Full Text] [Related]  

  • 11. Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.
    Prescrire Int; 2008 Aug; 17(96):143. PubMed ID: 19480098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer.
    El Saghir NS; Otrock ZK; Bleik JH
    BMC Cancer; 2005 Dec; 5():156. PubMed ID: 16332258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneously recovered severe thrombocytopaenia following zoledronic acid infusion for osteoporosis.
    Kulkarni P; Cushman T; Donthireddy V; Rao S
    BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26843222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First cases of calcium pyrophosphate deposition disease after zoledronic acid therapy.
    Couture G; Delzor F; Bagheri H; Micallef J; Ruyssen-Witrand A; Laroche M
    Joint Bone Spine; 2017 Mar; 84(2):213-215. PubMed ID: 27939801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual zoledronic acid for osteoporosis.
    BMJ Group
    Drug Ther Bull; 2008 Dec; 46(12):93-6. PubMed ID: 19056701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orbital Inflammation Secondary to Zoledronic Acid, a Rare Presentation.
    Muruganandam M; Sandhu H
    J Clin Rheumatol; 2016 Oct; 22(7):384. PubMed ID: 27488454
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical efficacy and safety of zoledronic acid in prostate and breast cancer.
    Doggrell SA
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1211-8. PubMed ID: 19761424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid.
    Olson KB; Hellie CM; Pienta KJ
    Urology; 2005 Sep; 66(3):658. PubMed ID: 16140106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trial.
    Otrock ZK; Azar ST; Shamseddeen WA; Habr D; Inati A; Koussa S; Mahfouz RA; Taher AT
    Ann Hematol; 2006 Sep; 85(9):605-9. PubMed ID: 16830143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid--once-yearly. Corticosteroid-induced osteoporosis: no benefit.
    Prescrire Int; 2010 Apr; 19(106):63. PubMed ID: 20568485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.